norethindrone has been researched along with goserelin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hagman, E; Kiilholma, P; Kivinen, S; Korhonen, M; Tuimala, R | 1 |
Holland, EF; Leather, AT; Studd, JW; Watson, NR | 2 |
Edmonds, DK | 1 |
Kivinen, S; Kujansuu, E; Rantala, I; Rintala, S; Teisala, K; Tuimala, R | 1 |
Farquharson, RG; Gazvani, MR; Pierce, SJ | 1 |
Franke, HR; Smit, WM; Vermes, I | 1 |
Franke, HR; Houben, PW; Snaaijer, FF; van der Mooren, MJ | 1 |
8 trial(s) available for norethindrone and goserelin
Article | Year |
---|---|
Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Endometriosis; Estradiol; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Laparoscopy; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Prospective Studies | 1995 |
The prevention of bone loss in young women treated with GnRH analogues with "add-back" estrogen therapy.
Topics: Administration, Oral; Adult; Bone Density; Double-Blind Method; Drug Implants; Estradiol; Estrogens; Female; Goserelin; Humans; Middle Aged; Norethindrone; Osteoporosis; Premenstrual Syndrome | 1993 |
Add-back therapy in the treatment of endometriosis: the European experience.
Topics: Administration, Cutaneous; Bone Density; Double-Blind Method; Drug Combinations; Endometriosis; Estradiol; Estrogen Replacement Therapy; Female; Goserelin; Humans; Injections; Luteinizing Hormone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Treatment Outcome | 1996 |
The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study.
Topics: Administration, Oral; Adult; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Goserelin; Humans; Middle Aged; Norethindrone; Premenstrual Syndrome; Progesterone Congeners; Surveys and Questionnaires | 1999 |
GnRH analogues and uterine leiomyomas. Effect of hormone replacement therapy on cell proliferation.
Topics: Adult; Antineoplastic Agents; Cell Division; Estradiol; Female; Goserelin; Hormones; Humans; Hysterectomy; Leiomyoma; Middle Aged; Nafarelin; Norethindrone; Premedication; Preoperative Care; Uterine Neoplasms | 1999 |
Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up.
Topics: Adult; Bone Density; Drug Implants; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Goserelin; Hip Joint; Hormone Replacement Therapy; Humans; Longitudinal Studies; Lumbosacral Region; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Spine | 2000 |
Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Hodgkin Disease; Humans; Inhibins; Norethindrone; Norethindrone Acetate; Pilot Projects; Primary Ovarian Insufficiency; Prospective Studies; Treatment Outcome | 2005 |
Treatment of dysfunctional uterine bleeding in the perimenopause: the effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment--a randomized, placebo-controlled, double-blind trial.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Climacteric; Double-Blind Method; Drug Combinations; Estradiol; Female; Goserelin; Hormone Replacement Therapy; Humans; Mammography; Metrorrhagia; Middle Aged; Norethindrone; Perimenopause | 2006 |